{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:41:54Z","timestamp":1793173314904,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ygyno.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T05:44:43Z","timestamp":1436247883000},"page":"731-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Increased prevalence of comorbid conditions in women with uterine cancer"],"prefix":"10.1016","volume":"138","author":[{"given":"Katherine C.","family":"Kurnit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy K.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"McHale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl C.","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Plaxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.07.004_bb0005","series-title":"American Cancer Society. Cancer.org.","author":"Endometrial (Uterine) Cancer","year":"2015"},{"key":"10.1016\/j.ygyno.2015.07.004_bb0010","series-title":"Surveillance, Epidemiology, and End Results Program. seer.cancer.gov.","author":"SEER Stat Fact Sheets: Endometrial Cancer","year":"2015"},{"key":"10.1016\/j.ygyno.2015.07.004_bb0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2005.01.007","article-title":"Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors","volume":"997","author":"Courneya","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COC.0b013e318277d5f4","article-title":"Impact of comorbid conditions on survival in endometrial cancer","volume":"37","author":"Nicholas","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2013.10.026","article-title":"Metformin use and endometrial cancer survival","volume":"132","author":"Nevadunsky","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0030","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2013.11.021","article-title":"Metformin is associated with improved survival in endometrial cancer","volume":"132","author":"Ko","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1525-1438.2007.00790.x","article-title":"Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis","volume":"17","author":"Chia","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.07.004_bb0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2012.04.013","article-title":"Cardiovascular disease is the leading cause of death among endometrial cancer patients","volume":"126","author":"Ward","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0045","unstructured":"Epi Info 7. Centers for Disease Control and Prevention. www.cdc.gov. Accessed 10 May 2014."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7525-7-17","article-title":"A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change","volume":"7","author":"von Gruenigan","year":"2009","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ygyno.2015.07.004_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2014.01.025","article-title":"Response to an exercise intervention after endometrial cancer: differences between obese and non-obese survivors","volume":"133","author":"Basen-Enquist","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygyno.2013.12.023","article-title":"Self-efficacy, quality of life, and weight loss in overweight\/obese endometrial cancer survivors (SUCCEED): a randomized controlled trial","volume":"132","author":"McCarroll","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0065","unstructured":"Comorbidities for FY2012. UHC. www.uhc.edu. Accessed 5 April 2015."},{"key":"10.1016\/j.ygyno.2015.07.004_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T15:49:36Z","timestamp":1582559376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815300664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0090825815300664"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.07.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased prevalence of comorbid conditions in women with uterine cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}